Apimeds Opens For Trading In Slow IPO Week
Sunday, May 11, 2025 1:00 PM EDT Image Source: www.gotcredit.com via Flickr Inflammation drug developer Apimeds Pharmaceuticals made its public debut this week, as it started trading at $4 on Friday and raised about $13.5 million in gross proceeds. Latest …